{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
clindamycin phosphate
to a specific field?
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2022)
Source URL:
First approved in 2013
Source:
21 CFR 333A
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(2023)
Source:
NDA217388
(2023)
Source URL:
First approved in 2023
Source:
NDA217388
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2021)
Source:
NDA214012
(2021)
Source URL:
First approved in 2021
Source:
NDA214012
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2020)
Source:
NDA214103
(2020)
Source URL:
First approved in 2020
Source:
NDA214103
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:zilebesiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:rapirosiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:tonlamarsen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID